Pediatric CNS Biorepository: Brain & MUSC Collaboration
“`html
combinedbrain and MUSC Partner to Launch Pediatric CNS Biorepository
Table of Contents
A new biorepository focused on pediatric central nervous system (CNS) tissue and biofluids will accelerate research into neurological diseases and aid in biomarker finding, established through a partnership between COMBINEDBrain and the Medical University of South Carolina (MUSC).
The partnership and its Goals
COMBINEDBrain and the Medical University of South Carolina (MUSC) announced a strategic partnership on February 29,2024,to create a biorepository specializing in pediatric CNS tissue and biofluids (News Medical, February 29, 2024). The initiative is spearheaded by Dr.Ramin Eskandari of MUSC and Dr. Anna Pfalzer of COMBINEDBrain.
The biorepository will collect and store high-quality human tissues – including brain, bone, and other soft tissues - alongside biofluids like cerebrospinal fluid (CSF) and blood.These resources will be made available to researchers globally, aiming to accelerate the advancement of treatments for neurological diseases and support drug companies in biomarker discovery and therapeutic development.
Unique Focus on Non-Diseased Pediatric Samples
What sets this biorepository apart is its focus on pediatric populations and, crucially, its collection of samples from individuals *without* diagnosed genetic or neurological diseases. This is a notable departure from many existing biobanks, which frequently enough concentrate on samples from patients already affected by conditions.
By including samples from healthy children, researchers can establish a baseline for comparison, making it easier to identify subtle changes associated with the early stages of neurological diseases. This approach is vital for understanding disease mechanisms and developing effective diagnostic tools.
Impact on Research and Drug Development
The availability of well-characterized pediatric CNS samples will have a broad impact on neurological research. Researchers will be able to:
- Expedite the identification of disease mechanisms.
- Enhance drug discovery efforts.
- Develop diagnostic and prognostic biomarkers.
Dr.Ramin Eskandari, Chief of the Department of Neurosurgery at MUSC, emphasized the transformative potential of the biorepository, stating it is indeed a “game-changer for both academia and the pharmaceutical industry” (News Medical, February 29, 2024).
Understanding Biorepositories
A biorepository is a facility that collects,processes,stores,and distributes biological samples for research purposes. These samples can include tissues, cells, DNA, RNA, proteins, and biofluids. biorepositories play a crucial role in advancing medical knowlege and developing new treatments. According to the National Cancer Institute, biorepositories are essential for translational research, bridging the gap between